HOME >> BIOLOGY >> NEWS
Universal flu vaccine being tested on humans

Ghent, Belgium -- A universal influenza vaccine that has been pioneered by researchers from VIB and Ghent University is being tested for the first time on humans by the British-American biotech company Acambis. This vaccine is intended to provide protection against all A strains of the virus that causes human influenza, including pandemic strains.

Flu

Influenza is an acute infection of the bronchial tubes and is caused by the influenza virus. Flu is probably one of the most underestimated diseases: it is highly contagious and causes people to feel deathly ill. An average of 5% of the worlds population is annually infected with this virus. This leads to 3 to 5 million hospitalizations and 250,000 to 500,000 deaths per year. In Belgium, an average of 1500 people die of flu each year. A more severe flu year - such as the winter of 1989-1990 - claimed in our country 4500 victims. Besides the annual flu epidemics, there is the possibility of a pandemic, which occurs every 10 to 30 years and causes more severe disease symptoms and a higher mortality rate. During the pandemic caused by the Spanish flu in 1918-1919, the number of deaths worldwide even rose to over 50 million.

Why an annual vaccine?

Todays flu vaccines need to be adapted every year and, consequently, they must also be administered again every year. The external structure of the flu virus mutates regularly, giving rise to new strains of flu. Due to these frequent mutations, the virus is able to elude the antibodies that have been built up during a previous infection or vaccination. This is why we run the risk of catching the flu each year and also why a new flu vaccine must be developed each year. A universal flu vaccine that provides broad and lifelong protection - like the vaccines we have for polio, hepatitis B or measles - is not yet available.

Universal flu vaccine

In the 1990s, VIB researchers connected to Ghent University, under
'"/>

Contact: Evy Vierstraete
info@vib.be
329-244-6611
VIB, Flanders Interuniversity Institute of Biotechnology
17-Jul-2007


Page: 1 2

Related biology news :

1. Universal design tackles little things with big impact
2. Phase II study of therapeutic vaccine shows efficacy in patients with metastatic colorectal cancer
3. Einstein researchers prototype vaccine could provide improved protection against tuberculosis
4. Handicapping tuberculosis may be the way to a better vaccine
5. Developing a more effective vaccine for tuberculosis
6. New target for HIV/AIDS drugs and vaccine discovered
7. Genomic analysis uncovers new targets for HIV vaccine
8. First genome-wide study of infectious disease opens new avenues for HIV treatment, vaccines
9. From clinical cancer research: rethinking therapeutic cancer vaccine trials
10. Paving the way toward a vaccine against Alzheimers disease
11. Mucosal-surface immune function discoveries could boost vaccine research

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/24/2019)... ... July 24, 2019 , ... ... PhD, a quality assurance expert with more than 20 years of experience working ... products, has joined the firm as an Expert Consultant. , Dr. Hartzfeld has ...
(Date:7/23/2019)... ... , ... NanoFUSE is pleased to announce the ... spine and orthopedic use. Bioactive glass is a calcium phosphate coated silica that ... orthopedics for over 30 years and now NanoFUSE Biologics has used advanced research ...
(Date:7/19/2019)... ... July 19, 2019 , ... ... Amorphous and Crystalline States – Insights from Synchrotron X-ray Pair Distribution (SXPDF) Studies”. ... along with Chris Benmore of Argonne National Laboratory and Gabriel de Araujo of ...
Breaking Biology News(10 mins):
(Date:8/6/2019)... ... August 05, 2019 , ... ... has been recognized as a distinguished leader by PharmaVOICE magazine, earning him a ... article in the magazine’s July/August special issue. , As the executive vice president ...
(Date:7/26/2019)... (PRWEB) , ... July 25, 2019 , ... ... biopharma leaders through off-the-record collaboration and dialogue, today announces its Boston BD ... Waterfront Hotel. As part of Biotech Week Boston , the event provides ...
(Date:7/17/2019)... ... July 15, 2019 , ... CRISPR is often thought ... certain trait can be removed, replaced, or edited, but Yiping Qi, assistant professor in ... these traditional applications in his latest publication in Nature Plants. In this comprehensive review, ...
(Date:7/9/2019)... ... 08, 2019 , ... Today, at the BIO World Congress on ... (NCGA) announced the winners of the Consider Corn Challenge II. Three winners were ... corn to produce biobased materials. , “Corn is a sustainable, abundant and affordable ...
Breaking Biology Technology:
Cached News: